Funding Opportunities - November 3, 2020

Nov 3, 2020, 03:00 AM by Melodi Moore

Listed are multiple funding opportunities for multiple career levels and COVID-19 with deadlines through Spring 2021.

Pre/Post Doctoral


AFPE Logo

Pre-Doctoral Research Fellowship in Pharmaceutical Sciences

The primary goal of the AFPE Pre-Doctoral Research Fellowship program is to positively impact patient and public health by supporting high performing students who possess the skill and aptitude to become outstanding scientists and leaders in the pharmaceutical industry, academia, and the government/nonprofit sectors.

AFPE also offers the following fellowships:

  • AFPE Regional Award
  • ASHP-AFPE Pre-Doctoral Fellowship
  • Dr. Paul B. Myrdal Memorial Pre-Doctoral Fellowship
  • Herb and Nina Demuth Memorial Award
  • Kappa Epsilon AFPE Fellowship
  • Phi Lambda Sigma-AFPE First Year Graduate School Fellowship
  • Rho Chi-AFPE First Year Graduate School Fellowship
  • Pre-Doctoral Fellowship in Health Outcome Disparities

Next Application Deadline:  December 2, 2020


Damon Runyon Logo

***Applicants can apply for only one of the following.***

Damon Runyon Postdoctoral Fellowship Award

The Damon Runyon Fellowship Award supports the training of the brightest postdoctoral scientists as they embark upon their research careers. This funding enables them to be mentored by established investigators in leading research laboratories across the country.

Applicants must have a new sponsor (joined lab on or after grant deadline) and their degree must be conferred between September 15, 2019 - March 15, 2021

Application Deadline:   March 15, 2021

Damon Runyon-Sohn Pediatric Cancer Fellowship Award

The Damon Runyon Cancer Research Foundation has joined together with the Sohn Conference Foundation, dedicated to curing pediatric cancers, to establish the Damon Runyon-Sohn Pediatric Cancer Fellowship Award. This award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers.

Candidates must apply for the fellowship under the guidance of a Sponsor—a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. Degrees must have been conferred between September 15, 2019 - March 15, 2021

Application Deadline:  March 15, 2021


Grass Foundation

Grass Fellowships in Neuroscience

Summer fellowships at the Marine Biological Laboratory (MBL) in Woods Hole, Massachusetts, USA, support investigator-designed, independent research projects by scientists early in their career. Supported approaches include neurophysiology, biophysics, integrative neurobiology, neuroethology, neuroanatomy, neuropharmacology, systems neuroscience, cellular and developmental neurobiology, and computational approaches to neural systems. The Foundation also has a longstanding interest in epilepsy-related research.  The duration of the program is 14 weeks starting Memorial Day Monday and includes research support including laboratory space, animals, equipment and supplies as well as housing, a daily meal allowance and round-trip travel to the MBL for the fellow’s spouse or legal domestic partner, and dependent children.

Application Deadline:  December 5, 2020


banner-nihlogo

Predoctoral/Postdoctoral Fellowships

PA-21-052  Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)

The purpose of this Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research award is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from diverse backgrounds including those from groups that are underrepresented in the biomedical, behavioral, or clinical research workforce.

Through this award program, promising predoctoral students will obtain individualized, mentored research training from outstanding faculty sponsors while conducting well-defined research projects in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training is expected to clearly enhance the individual's potential to develop into a productive, independent research scientist.

This Funding Opportunity Announcement (FOA) does not allow candidates to propose to lead an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial,  but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Next Application Deadline:  December 8, 2020




Early Career

American Society of Transplantation
AST Research Network Career Development Grants: 2021 Fellowship Research Grant

The purpose of AST Research Network Fellowship Research Grants is to support the research of individuals who have spent two years or less performing research in the area of solid organ transplantation (and/or immunology relating to solid organ transplant) since obtaining their last doctoral degree (PhD, MD, PharmD, or equivalent).

Application Deadline:  December 1, 2020 at 11:59 pm PST


American College of Gastroenterology

Clinical Research Award

The ACG Institute for Clinical Research and Education and the American College of Gastroenterology (ACG) supports junior investigators working toward independent careers in clinical research in gastroenterology or hepatology.

Application Deadline:  December 4, 2020 AT 11:59 PM EDT


Doris Duke

Doris Duke Charitable Foundation (DDCF) Clinical Scientist Development Award

The Clinical Scientist Development Award consists of $150,000 annual direct costs plus $15,000 (10%) annual indirect costs for three years. The priority of the CSDA program is to fund outstanding individuals with potential for clinical research careers, whose projects will address highly significant research questions and lead to career advancement. DDCF does not have funding priorities based on disease area or research type.  Any Instructor or Assistant Professor rank working at US degree-granting institutions to support clinical research that will enable their transition to independent research funding is eligible.

Pre-proposal applications due:  November 13, 2020, 3 pm ET


Grass Foundation

Grass Fellowships in Neuroscience

Summer fellowships at the Marine Biological Laboratory (MBL) in Woods Hole, Massachusetts, USA, support investigator-designed, independent research projects by scientists early in their career. Supported approaches include neurophysiology, biophysics, integrative neurobiology, neuroethology, neuroanatomy, neuropharmacology, systems neuroscience, cellular and developmental neurobiology, and computational approaches to neural systems. The Foundation also has a longstanding interest in epilepsy-related research.  The duration of the program is 14 weeks starting Memorial Day Monday and includes research support including laboratory space, animals, equipment and supplies as well as housing, a daily meal allowance and round-trip travel to the MBL for the fellow’s spouse or legal domestic partner, and dependent children.

Application Deadline:  December 5, 2020



Multi-Level Funding

HABRI

Addressing Evidence-Based Health Benefits of Human-Animal Interaction

HABRI is calling for research proposals to investigate the health outcomes of pet ownership and/or animal-assisted activity or therapy, both for the people and the animals involved. Proposals should have a strong theoretical framework and focus on innovative approaches to studying the health effects of companion animals on humans within the following broad categories:

  • Child Health and Development
  • Healthy Aging
  • Mental & Physical Health and Wellness

Application Deadline: Thursday, February 11, 2021 at 11:59 PM EDT


Lasker Foundation

2021 Lasker Award Nominations Open

The Lasker Awards were canceled in 2020 owing to the global pandemic. They will be given again in 2021. Nominations may be made for the following awards using the criteria listed by each.  Anyone who has made an original and significant contribution in basic or clinical medical research, or in public service, is eligible for nomination.  Colleagues familiar with the nominee(s)'s work and with the relevant field of research (or area of public service) are ideal nominators. Self-nominations or nominations written by the candidates themselves will not be considered by the Jury.

Albert Lasker Basic Medical Research Award: For a fundamental discovery that opens up a new area of biomedical science.

Lasker~DeBakey Clinical Medical Research Award: For a major advance that improves the lives of many thousands of people.

Lasker~Koshland Special Achievement Award in Medical Science: For research accomplishments and scientific statesmanship that engender the deepest feelings of awe and respect.  Open for 2021

Nomination Deadline:  February 1, 2021


banner-nihlogo

Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

The NIH has a strong interest in the diversity of the NIH-funded research enterprise (see NIH notice NOT-OD-20-031) and encourages institutions to diversify their scientific workforce by increasing the participation of individuals from groups identified as underrepresented in the biomedical, clinical, behavioral, and social sciences. Participating institutes continue to support these efforts through ongoing programs and supplement funding opportunities. This specific notice reiterates this interest and encourages eligible grant and cooperative agreement awardees in the HEAL Initiative community to apply for administrative supplements in response to PA-20-222 (or any subsequent reissuances), Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed). This notice is part of the NIH’s Helping to End Addiction Long-term (HEAL) Initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative is a trans-NIH effort to (1) improve prevention and treatment strategies for opioid misuse and addiction and (2) enhance pain management. More information about the HEAL Initiative is available at: https://heal.nih.gov.

Notice of Special Interest (NOSI): Use of Predictive Analytics to Accelerate Late-Stage Implementation Research to Address Heart, Lung, Blood, and Sleep Disorders

National Heart, Lung, and Blood Institute (NHLBI) is issuing this Notice of Special Interest (NOSI) to leverage existing data resources using Predictive Analytics Implementation Research (PAIR) that utilizes complex and innovative methodologies and modeling techniques to rely on integration of existing data to inform the designs (and often test) implementation strategies for heart, lung, blood, and sleep (HLBS) conditions. NHLBI also encourages applications which focus on the development of advance modeling techniques and data reporting, which would be publicly available and could be used to inform subsequent implementation strategies to address HLBS conditions.

Submit applications for this NOSI using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.

  • PAR-19-274 - Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
  • PA-20-185  - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed

Regular Submission Dates Apply.


PHRMA_Logo

Valuing Health Equity Challenge Award

The PhRMA Foundation has established a new Challenge Award focused on finding solutions to racial health disparities. This Challenge Award aims to inspire bold and vital research on how value assessment can better capture evidence regarding diverse populations and drivers of health disparities.

Submissions should be based on bold and fresh ideas to advance methods and processes associated with value assessment (and/or value elements). The PhRMA Foundation seeks papers that describe solutions to the following question:

“How can value assessment methods and processes better account for populations that are typically underrepresented in research and drivers of health disparities?”

Letters of Intent due:  December 1, 2020



COVID-19

banner-nihlogo

Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)

National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes, i.e., “coronavirus disease 2019” (COVID-19). NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial.

The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. Examples include the following:

  • Testing a candidate therapy to treat COVID-19 that was already identified with a publicly available computational approach.
  • Testing of existing therapeutic candidates that work on mechanistic targets shared among other viruses that may be relevant to SARS-CoV-2.

NCATS is soliciting applications to PAR-17-465PAR-18-462, and PAR-18-332

***This notice applies to receipt dates on or after October 30, 2020 and subsequent receipt dates through March 16, 2021.***

Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection

The purpose of this notice is to communicate National Institute on Drug Abuse (NIDA’s) interest in supporting research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection.

During this pandemic, requirements of “Stay-at-Home” to reduce exposure, social isolation, lack of employment and lost incomes have raised the level of anxiety among individuals and may have led to increased use of tobacco and marijuana. Therefore, it is scientifically relevant to explore the medical consequences of smoking and vaping and the effects of tobacco and marijuana exposure in relation to COVID-19. Of relevance are studies in individuals at the forefront of indispensable jobs, in individuals with substance-use disorders (SUD) (narcotics, stimulants, sedatives, etc.), in individuals with HIV and other immunocompromised populations, in disenfranchised minorities, and in adolescents whose lives have been distorted by the pandemic. Remarkably, vaping nicotine and marijuana have risen sharply in the past 3 years among adolescents and young adults, a phenomenon that may increase vulnerability of these individuals to COVID-19 infection. Whereas mortality appears lower in adolescents and young adults, they can suffer from respiratory or cardiovascular long-term morbidity at a time they can be significant transmitters of infection.

Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.

  • PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
  • PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
  • PA-20-195- NIH Exploratory/Developmental Research Grant (Parent R21Clinical Trial Not Allowed)

***Applies to due dates on or after January 7, 2021***

Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is to support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes in organs, tissues, and biological systems of specific interest to NIDDK. These include diabetes and other metabolic diseases, obesity, and endocrine, digestive, liver, pancreas, kidney, urological, and hematologic tissues and diseases.

Applications Due:  December 16, 2020